Posted tagged ‘FDA’

Spiriva Safe, says the FDA

January 18, 2010

The mainstay of COPD management is bronchodilatation – the local, and national guidelines rely on beta-2 agonists, and anti-cholinergics.  Recent(ish) data from the TORCH study suggested that inhaled corticosteroids increase the risk of fatal and non-fatal pneumonias.  Unopposed long acting beta agonists have been linked with increased cardiovascular death in asthmatics, although not in COPD.  The most recent ‘scare’ has been whether Spiriva increases cardiovascular death in COPD patients.  Today the FDA rule that there is no compelling evidence to that effect.